Glucocorticoid resistance in inflammatory diseases. (Q37501546)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19482216 AND SRC:MED&resulttype=core&format=json

29 January 2020

review article

1 reference

title

Glucocorticoid resistance in inflammatory diseases (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19482216 AND SRC:MED&resulttype=core&format=json

glucocorticoid resistance

29 January 2020

main subject

inflammation

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19482216 AND SRC:MED&resulttype=core&format=json

29 January 2020

1

Peter J Barnes

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19482216 AND SRC:MED&resulttype=core&format=json

29 January 2020

language of work or name

English

0 references

publication date

1 May 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19482216 AND SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19482216 AND SRC:MED&resulttype=core&format=json

29 January 2020

volume

373

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19482216 AND SRC:MED&resulttype=core&format=json

29 January 2020

issue

9678

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19482216 AND SRC:MED&resulttype=core&format=json

29 January 2020

page(s)

1905-1917

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19482216 AND SRC:MED&resulttype=core&format=json

Global strategy for asthma management and prevention: GINA executive summary.

29 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Glucocorticoid resistance in asthma

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Steroid Resistance in Bronchial Asthma

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Hypothalamic-pituitary-adrenal axis in corticosteroid-resistant bronchial asthma

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Corticosteroid pharmacokinetics in asthma.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Dysregulation of interleukin 4, interleukin 5, and interferon gamma gene expression in steroid-resistant asthma

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Airway remodeling and lack of bronchodilator response in steroid-resistant asthma

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Asthma and cigarette smoking.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Resistance to methylprednisolone in cultures of blood mononuclear cells from glucocorticoid-resistant asthmatic patients.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Glucocorticoid resistance in chronic asthma. Peripheral blood T lymphocyte activation and comparison of the T lymphocyte inhibitory effects of glucocorticoids and cyclosporin A.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Relative corticosteroid insensitivity of peripheral blood mononuclear cells in severe asthma

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Relative corticosteroid insensitivity of alveolar macrophages in severe asthma compared with non-severe asthma

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Cutaneous vasoconstrictor response to glucocorticoids in asthma.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Corticosteroid resistance in rheumatoid arthritis: molecular and cellular perspectives

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

The effect of methylprednisolone on proliferation of PBMCs obtained from steroid-sensitive and steroid-resistant rheumatoid arthritis patients

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Glucocorticoid resistance in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Predicting therapeutic outcome in severe ulcerative colitis by measuring in vitro steroid sensitivity of proliferating peripheral blood lymphocytes

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Apoptosis of lymphocytes induced by glucocorticoids and relationship to therapeutic efficacy in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Superantigens, steroid insensitivity and innate immunity in atopic eczema

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Inhaled corticosteroids for stable chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Methodological issues in therapeutic trials of COPD.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Effect of High Dose Inhaled Steroid on Cells, Cytokines, and Proteases in Induced Sputum in Chronic Obstructive Pulmonary Disease

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Effect of salmeterol/fluticasone propionate on airway inflammation in COPD: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Immunology of asthma and chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Do inhaled corticosteroids impair long-term growth in prepubertal cystic fibrosis patients?

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Corticosteroids for idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: meta-analysis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Innate immunity, macrophage activation, and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

How corticosteroids control inflammation: Quintiles Prize Lecture 2005

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Antiinflammatory action of glucocorticoids--new mechanisms for old drugs

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Importin α: a multipurpose nuclear-transport receptor

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Importin 13 regulates nuclear import of the glucocorticoid receptor in airway epithelial cells

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

The physiology of human glucocorticoid receptor beta (hGRbeta) and glucocorticoid resistance.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Corticosteroid effects on cell signalling

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

MAP kinase phosphatase 1: a novel mediator of biological effects of glucocorticoids?

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Negative glucocorticoid receptor response elements and their role in glucocorticoid action

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

How do corticosteroids work in asthma?

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Histone acetylation and deacetylation: importance in inflammatory lung diseases

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB suppression

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Glucocorticoid inhibition of granulocyte macrophage-colony-stimulating factor from T cells is independent of control by nuclear factor-kappaB and conserved lymphokine element 0.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Glucocorticoids regulate tristetraprolin synthesis and posttranscriptionally regulate tumor necrosis factor alpha inflammatory signaling.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Profiling of genes expressed in peripheral blood mononuclear cells predicts glucocorticoid sensitivity in asthma patients

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Use of gene expression profiling to identify a novel glucocorticoid sensitivity determining gene, BMPRII.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Chemical mutational analysis of the human glucocorticoid receptor cDNA in glucocorticoid-resistant bronchial asthma.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Glucocorticoid receptor polymorphism affects transrepression but not transactivation

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Steroid-resistant asthma. Cellular mechanisms contributing to inadequate response to glucocorticoid therapy

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

p38 Mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: role in steroid-insensitive asthma

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Defective glucocorticoid receptor nuclear translocation and altered histone acetylation patterns in glucocorticoid-resistant patients

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

p38 Mitogen-activated protein kinase (MAPK) is a key mediator in glucocorticoid-induced apoptosis of lymphoid cells: correlation between p38 MAPK activation and site-specific phosphorylation of the human glucocorticoid receptor at serine 211.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Inhibition of glucocorticoid receptor-mediated transcriptional activation by p38 mitogen-activated protein (MAP) kinase

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Steroid receptor phosphorylation: a key modulator of multiple receptor functions

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

A role for STAT5 in the pathogenesis of IL-2-induced glucocorticoid resistance

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Modulation of glucocorticoid receptor function via phosphorylation.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Superantigen-induced corticosteroid resistance of human T cells occurs through activation of the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase (MEK-ERK) pathway

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Inhibition of glucocorticoid receptor binding by nitric oxide

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Proteasome-mediated glucocorticoid receptor degradation restricts transcriptional signaling by glucocorticoids.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Increased glucocorticoid receptor beta in airway cells of glucocorticoid-insensitive asthma.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Glucocorticoid resistance in asthma is associated with elevated in vivo expression of the glucocorticoid receptor beta-isoform

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

The differential expression of corticosteroid receptor isoforms in corticosteroid-resistant and -sensitive patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Quantitative analysis for human glucocorticoid receptor alpha/beta mRNA in IBD.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Alpha and beta glucocorticoid receptors: relevance in airway diseases.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Glucocorticoid receptor alpha and beta in glucocorticoid dependent asthma

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant negative beta isoform: a mechanism for the generation of glucocorticoid resistance.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Microbial superantigens induce glucocorticoid receptor beta and steroid resistance in a nasal explant model

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Increased glucocorticoid receptor beta alters steroid response in glucocorticoid-insensitive asthma

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Human glucocorticoid receptor beta binds RU-486 and is transcriptionally active.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Abnormal glucocorticoid receptor-activator protein 1 interaction in steroid-resistant asthma

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Systemic glucocorticoid reduces bronchial mucosal activation of activator protein 1 components in glucocorticoid-sensitive but not glucocorticoid-resistant asthmatic patients

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Corticosteroid-resistant bronchial asthma is associated with increased c-fos expression in monocytes and T lymphocytes

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Cytoskeletal and cell contact control of the glucocorticoid pathway

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Expression of nonmuscle cofilin-1 and steroid responsiveness in severe asthma

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Decreased histone deacetylase activity in chronic obstructive pulmonary disease.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Role of Brg1 and HDAC2 in GR trans-repression of the pituitary POMC gene and misexpression in Cushing disease.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Reduced histone deacetylase in COPD: clinical implications

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Oxidative stress reduces histone deacetylase 2 activity and enhances IL-8 gene expression: role of tyrosine nitration

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Oxidative stress and redox regulation of lung inflammation in COPD.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Regulatory T cells and IL-10 in allergic inflammation

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Overcoming drug resistance induced by P-glycoprotein on lymphocytes in patients with refractory rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Polymorphisms in multidrug resistance 1 (MDR1) gene are associated with refractory Crohn disease and ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

The effect of 3435C>T MDR1 gene polymorphism on rheumatoid arthritis treatment with disease-modifying antirheumatic drugs

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

The macrophage migration inhibitory factor-glucocorticoid dyad: regulation of inflammation and immunity

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Macrophage migration inhibitory factor promotes innate immune responses by suppressing glucocorticoid-induced expression of mitogen-activated protein kinase phosphatase-1.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Macrophage migration inhibitory factor has a proinflammatory activity via the p38 pathway in glucocorticoid-resistant ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Mechanisms of disease: macrophage migration inhibitory factor in SLE, RA and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Human circulating eosinophils secrete macrophage migration inhibitory factor (MIF). Potential role in asthma

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Selective glucocorticoid receptor agonists (SEGRAs): novel ligands with an improved therapeutic index.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Colectomy rate in steroid-refractory colitis initially responsive to cyclosporin: a long-term retrospective cohort study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Cyclosporine and tacrolimus for the treatment of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

p38alpha-selective mitogen-activated protein kinase inhibitor SD-282 reduces inflammation in a subchronic model of tobacco smoke-induced airway inflammation

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Is there a future for small molecule drugs in the treatment of rheumatic diseases?

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

p38 MAP-kinases pathway regulation, function and role in human diseases

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

The IKK NF-kappa B system: a treasure trove for drug development

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Effects of smoking cessation on lung function and airway inflammation in smokers with asthma.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Basiliximab for the treatment of steroid-resistant ulcerative colitis: further experience in moderate and severe disease

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Pharmacological strategies for overcoming multidrug resistance

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Macrophage migration inhibitory factor: a therapeutic target across inflammatory diseases.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Theophylline restores histone deacetylase activity and steroid responses in COPD macrophages.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Targeting phosphoinositide 3-kinase: moving towards therapy

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

PI3K delta and PI3K gamma: partners in crime in inflammation in rheumatoid arthritis and beyond?

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

Targeting histone deacetylase 2 in chronic obstructive pulmonary disease treatment

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(09)60326-3

7 January 2021

10.1016/S0140-6736(09)60326-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19482216 AND SRC:MED&resulttype=core&format=json

29 January 2020

1 reference